Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored.
作者信息
Zarbock Alexander, Chawla Lakhmir, Bellomo Rinaldo
机构信息
Department of Anaesthesiology, Intensive Care and Pain Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Geb. A1, 48149, Munster, Germany.
Veterans Affairs Medical Center, San Diego, CA, USA.
出版信息
Crit Care. 2021 Nov 14;25(1):389. doi: 10.1186/s13054-021-03816-x.
Abstract
摘要
相似文献
1
Why the renin-angiotensin-aldosterone system (RAAS) in critically ill patients can no longer be ignored.为何重症患者体内的肾素-血管紧张素-醛固酮系统（RAAS）不容忽视。
Crit Care. 2021 Nov 14;25(1):389. doi: 10.1186/s13054-021-03816-x.
2
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitors.钾离子稳态和肾素-血管紧张素-醛固酮系统抑制剂。
Clin J Am Soc Nephrol. 2010 Mar;5(3):531-48. doi: 10.2215/CJN.07821109. Epub 2010 Feb 11.
3
Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.肾素-血管紧张素-醛固酮系统的抑制作用：聚焦于阿利吉仑。
J Assoc Physicians India. 2010 Feb;58:102-8.
4
Hypertension: renin-angiotensin-aldosterone system alterations.高血压：肾素-血管紧张素-醛固酮系统改变。
Circ Res. 2015 Mar 13;116(6):960-75. doi: 10.1161/CIRCRESAHA.116.303587.
5
The renin-angiotensin-aldosterone system and heart failure.肾素-血管紧张素-醛固酮系统与心力衰竭。
Cardiol Clin. 2014 Feb;32(1):21-32, vii. doi: 10.1016/j.ccl.2013.09.002.
6
Influence of renin-angiotensin-aldosterone system-blocking drugs on peritoneal membrane in peritoneal dialysis patients.肾素-血管紧张素-醛固酮系统阻断药物对腹膜透析患者腹膜的影响。
Ther Apher Dial. 2013 Aug;17(4):425-30. doi: 10.1111/1744-9987.12091.
7
Renin-angiotensin aldosterone profile before and after angiotensin-converting enzyme-inhibitor administration in dogs with angiotensin-converting enzyme gene polymorphism.血管紧张素转换酶基因多态性犬应用血管紧张素转换酶抑制剂前后的肾素-血管紧张素-醛固酮谱。
J Vet Intern Med. 2020 Mar;34(2):600-606. doi: 10.1111/jvim.15746. Epub 2020 Feb 29.
8
Evaluation of laboratory disturbance risk when adding low-dose cotrimoxazole for PJP prophylaxis to regimens of high-grade glioma patients taking RAAS inhibitors.在服用RAAS抑制剂的高级别胶质瘤患者的治疗方案中添加低剂量复方新诺明用于预防肺孢子菌肺炎时实验室干扰风险的评估。
J Oncol Pharm Pract. 2019 Sep;25(6):1366-1373. doi: 10.1177/1078155218792985. Epub 2018 Aug 19.
9
Monotherapy of RAAS blockers and mobilization of aldosterone: A mechanistic perspective study in kidney disease.RAAS 阻滞剂的单药治疗与醛固酮动员：肾脏病的一种机制研究。
Chem Biol Interact. 2020 Feb 1;317:108975. doi: 10.1016/j.cbi.2020.108975. Epub 2020 Feb 4.
10
[Regulatory mechanisms for the renin-angiotensin-aldosterone system].[肾素-血管紧张素-醛固酮系统的调节机制]
Nihon Rinsho. 2012 Sep;70(9):1477-81.
引用本文的文献
1
Trajectories of urea‑to‑creatinine ratio and risk of clinical outcomes in survivors of acute kidney disease: a population-based study.急性肾疾病幸存者中尿素与肌酐比值轨迹及临床结局风险：一项基于人群的研究
Clin Kidney J. 2025 May 29;18(6):sfaf175. doi: 10.1093/ckj/sfaf175. eCollection 2025 Jun.
2
The rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients.rs1799752 变异与 COVID-19 严重程度相关，但与住院和康复患者的血清 ACE 活性无关。
Int J Mol Sci. 2023 Apr 21;24(8):7678. doi: 10.3390/ijms24087678.
3
Mineralocorticoid receptor-antagonism prevents COVID-19-dependent glycocalyx damage.醛固酮受体拮抗剂可预防 COVID-19 依赖性糖萼损伤。
Pflugers Arch. 2022 Oct;474(10):1069-1076. doi: 10.1007/s00424-022-02726-3. Epub 2022 Jul 22.
4
The Renin-Angiotensin System as a Component of Biotrauma in Acute Respiratory Distress Syndrome.肾素-血管紧张素系统作为急性呼吸窘迫综合征生物创伤的一个组成部分。
Front Physiol. 2022 Apr 13;12:806062. doi: 10.3389/fphys.2021.806062. eCollection 2021.
5
Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan.允许性氮质血症在急性肾损伤期间可促进更快的肾功能恢复和减少肾纤维化：一个假说和临床开发计划。
Crit Care. 2022 Apr 28;26(1):116. doi: 10.1186/s13054-022-03988-0.
本文引用的文献
1
Serum renin and major adverse kidney events in critically ill patients: a multicenter prospective study.危重症患者血清肾素与主要不良肾脏事件：一项多中心前瞻性研究。
Crit Care. 2021 Aug 14;25(1):294. doi: 10.1186/s13054-021-03725-z.
2
Renin Kinetics Are Superior to Lactate Kinetics for Predicting In-Hospital Mortality in Hypotensive Critically Ill Patients.肾素动力学优于乳酸动力学预测低血压危重症患者住院死亡率。
Crit Care Med. 2022 Jan 1;50(1):50-60. doi: 10.1097/CCM.0000000000005143.
3
COVID-19 pathophysiology may be driven by an imbalance in the renin-angiotensin-aldosterone system.COVID-19 的病理生理学可能是由肾素-血管紧张素-醛固酮系统失衡驱动的。
Nat Commun. 2021 Apr 23;12(1):2417. doi: 10.1038/s41467-021-22713-z.
4
Kinetic Changes of Plasma Renin Concentrations Predict Acute Kidney Injury in Cardiac Surgery Patients.血浆肾素浓度的动力学变化可预测心脏手术患者的急性肾损伤。
Am J Respir Crit Care Med. 2021 May 1;203(9):1119-1126. doi: 10.1164/rccm.202005-2050OC.
5
Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury.血管紧张素 II 型 1 受体信号转导受损导致脓毒症引起的急性肾损伤。
Kidney Int. 2021 Jan;99(1):148-160. doi: 10.1016/j.kint.2020.07.047. Epub 2020 Aug 31.
6
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial.血管扩张性休克儿茶酚胺抵抗患者应用血管紧张素 II 治疗与肾素及生存关系的临床研究
Am J Respir Crit Care Med. 2020 Nov 1;202(9):1253-1261. doi: 10.1164/rccm.201911-2172OC.
7
Renin as a Marker of Tissue-Perfusion and Prognosis in Critically Ill Patients.肾素作为危重症患者组织灌注和预后的标志物。
Crit Care Med. 2019 Feb;47(2):152-158. doi: 10.1097/CCM.0000000000003544.
8
Pericytes in the renal vasculature: roles in health and disease.肾脏血管中的周细胞：在健康和疾病中的作用。
Nat Rev Nephrol. 2018 Aug;14(8):521-534. doi: 10.1038/s41581-018-0032-4.
9
Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017 : Expert opinion of the Working Group on Prevention, AKI section, European Society of Intensive Care Medicine.重症监护病房中急性肾损伤的预防与肾功能保护：2017年更新：欧洲重症监护医学学会急性肾损伤预防工作组专家意见
Intensive Care Med. 2017 Jun;43(6):730-749. doi: 10.1007/s00134-017-4832-y. Epub 2017 Jun 2.
10
The use of angiotensin II in distributive shock.血管紧张素II在分布性休克中的应用。
Crit Care. 2016 May 27;20(1):137. doi: 10.1186/s13054-016-1306-5.
Zotero 插件